HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Capital Management, Inc | 21 | $802 | 0.00% |
| Amundi | 14,600 | $533,630 | 0.00% |
| WOLVERINE TRADING, LLC | 5,691 | $217,396 | 0.00% |
| Clearstead Advisors, LLC | 156 | $5,960 | 0.00% |
| WOLVERINE TRADING, LLC | 8,300 | $317,060 | 0.00% |
| Global Retirement Partners, LLC | 59 | $2,197 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 15 | $573 | 0.00% |
| SRS Capital Advisors, Inc. | 54 | $2,064 | 0.00% |
| BESSEMER GROUP INC | 211 | $8 | 0.00% |
| Baker Avenue Asset Management, LP | 7 | $267 | 0.00% |
| Walleye Capital LLC | 3,400 | $129,880 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34,100 | $1,302,620 | 0.00% |
| Walleye Capital LLC | 4,800 | $183,360 | 0.00% |
| Citadel Advisors | 7,400 | $282,680 | 0.00% |
| JNBA Financial Advisors | 24 | $917 | 0.00% |
| FMR LLC | 126,818 | $4,844,456 | 0.00% |
| Citadel Advisors | 36,100 | $1,379,020 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 50 | $1,910 | 0.00% |
| AdvisorNet Financial, Inc | 19 | $726 | 0.00% |
| Prestige Wealth Management Group LLC | 8 | $306 | 0.00% |
External links
This page lists HALOZYME THERAPEUTICS INC's shareholders in Q3 2023. To view HALOZYME THERAPEUTICS INC's shareholder history, click here.